| Mary Louise Guerry-force, MD | |
|
800 Montclair Rd, Birmingham, AL 35213-1908 | |
| (205) 592-5336 | |
| (205) 592-5646 |
| Full Name | Mary Louise Guerry-force |
|---|---|
| Gender | Female |
| Speciality | |
| Experience | Years |
| Location | 800 Montclair Rd, Birmingham, Alabama |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720150196 | NPI | - | NPPES |
| 1110030 | Other | UNITED HEALTHCARE | |
| 0004036508 | Other | AETNA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | MD.13390 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mary Louise Guerry-force, MD 402 Office Park Dr, Suite 200, Birmingham, AL 35223-2417 Ph: (205) 802-5220 | Mary Louise Guerry-force, MD 800 Montclair Rd, Birmingham, AL 35213-1908 Ph: (205) 592-5336 |
News Archive
Improving MR exam workflow without sacrificing patient safety, exam comfort or image quality is a goal for many health care facilities. Overlake Hospital in Bellevue, Wash., selected Toshiba America Medical Systems' patient-friendly Vantage Titan ultra-short, open bore MR system to achieve this goal in its new MR facility.
A team of Roswell Park Cancer Institute researchers has developed and evaluated the first intravital microscopy system shown to be safe for use in humans. Writing in the journal Nature Communications, the scientists report that their proprietary technology enabled them, for the first time ever, to visualize tumor blood vessels in real time.
A new study has been released on the bioRxiv* preprint server, which deals with a comprehensive survey on alternative splicing concerning SARS-CoV-2 infection. This study has also included two other betacoronavirurses (SARS-CoV and MERS), a control set of unrelated viruses, and a bacterium, namely, Streptococcus pneumonia. The study findings suggest that several cellular parameters are affected owing to a betacoronavirus infection, which in turn affects some genes and invariably various biological functions.
BioDirection, Inc., a privately held medical device company developing novel and rapid point-of-care products for the objective detection of concussion and other traumatic brain injury (TBI), announced today results from a pre-clinical study show that the company's Tbit™ System for the detection of TBI is sensitive, provides actionable results in point-of-care settings, and has the potential to reduce the number of unnecessary computerized tomography (CT) scans.
› Verified 1 days ago
Dr. Kyle Charles Mills, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 3550 Independence Dr, Birmingham, AL 35209 Phone: 205-949-2800 Fax: 205-949-2801 | |
Leona Council, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 619 19th St S, Birmingham, AL 35249 Phone: 205-934-5038 | |
Dr. Alexander Wong, M.D. Pathology Medicare: Medicare Enrolled Practice Location: 3550 Independence Dr, Birmingham, AL 35209 Phone: 205-949-2806 Fax: 205-949-2875 | |
Dr. David Ullman, M.D. Pathology Medicare: Medicare Enrolled Practice Location: 625 19th St S, Birmingham, AL 35233 Phone: 205-934-4977 | |
Dr. Jonathan G Phillips, MD Pathology Medicare: Medicare Enrolled Practice Location: 924 Montclair Rd, Ste 200, Birmingham, AL 35213 Phone: 205-591-7999 Fax: 205-591-5051 | |
Thomas S Winokur, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 619 19th Street South, Birmingham, AL 35233 Phone: 205-934-6600 | |
Isam Eltoum, Pathology Medicare: Accepting Medicare Assignments Practice Location: 2000 6th Ave S, Birmingham, AL 35233 Phone: 205-934-9999 |